Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-25 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-25 is a macrocyclic pyridotriazine derivative. Cap-dependent endonuclease-IN-25 has the potential for the research of viral infections caused by viruses belonging to the Orthomyxoviridae family (extracted from patent WO2020075080A1, compound 4)[1].
Web ID
– HY-144068
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C25H25N3O3
References
– [1] Robert Than Hendricks, et al. Macrocyclic flu endonuclease inhibitors. Patent WO2020075080A1.
CAS Number
– 2415788-71-3
Molecular Weight
– 415.48
SMILES
– O=C1C=CN2C(C(N3CN2C(C4=C(CCCCC3)C=CC=C4)C5=CC=CC=C5)=O)=C1O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
